Abstract:Two precision‐targeted nanoparticles PD‐L1@Cur‐NPs and PD‐1@AS‐NPs are constructed for cancer treatment. PD‐L1@Cur‐NPs can precisely target tumor cells to eradicate tumor cells or induce them apoptosis. PD‐1@AS‐NPs can precisely target T cells to activate the T cell‐mediated immune system and induce antitumor immune responses. These two nanoparticles have good synergistic effect and show stronger antitumor effect after combination. Cancer has emerged as a significant threat that gravely endanger human health. Anti‐tumor immunotherapy has now emerged as an important treatment for cancer. However, immunosuppressive tumor microenvironment limits the antitumor immunity. The importance of the immune system in the cancer treatment process must be emphasized. Herein, two precision‐targeted nanoparticles PD‐L1@Cur‐NPs and PD‐1@AS‐NPs are constructed for cancer treatment. PD‐L1@Cur‐NPs can precisely target tumor cells in vivo to eradicate tumor cells or induce them apoptosis. PD‐1@AS‐NPs can precisely target T cells in vivo to activate the T cell‐mediated immune system and induce antitumor immune responses. Furthermore, these two nanoparticles have good synergistic effect and show stronger antitumor effect after combination. After treatment with the combination of two nanoparticles, the tumor volumes of C57BL/6 tumor‐bearing mice are significantly reduced. Moreover, the percentage of CD8+T cells and CD4+T cells in the tumor significantly increased, and the percentage of regulatory T cells significantly decreased. The percentage of memory T cells and memory effector T cells in the spleen also significantly increased after treatment, suggesting that the antitumor immunity is activated after treatment. This study provides a new antitumor treatment strategy combining chemotherapy and immunotherapy, which has good application prospect.

Multiboosting of Cancer Immunotherapy by a Core-Shell Delivery System.

Combination of GNRs-PEI/cGAMP-laden Macrophages-Based Photothermal Induced in Situ Tumor Vaccines and Immune Checkpoint Blockade for Synergistic Anti-Tumor Immunotherapy.

Core-shell Tecto Dendrimer-Mediated Cooperative Chemoimmunotherapy of Breast Cancer

A multifunctional CaCO3 bioreactor coated with coordination polymers enhances cancer immunotherapy

Functional Core/Shell Drug Nanoparticles for Highly Effective Synergistic Cancer Therapy

Systematic co-delivery of dual agonists to enhance cancer immunotherapy

Multifunctional Nanoparticle-Loaded Injectable Alginate Hydrogels with Deep Tumor Penetration for Enhanced Chemo-Immunotherapy of Cancer

Core-shell nanomedicine based on multifunctional tetrahedral DNA nanostructures for synergistic enhancement of tumor chemodynamic/chemo-immunotherapy

Dual Synergistic Tumor‐Specific Polymeric Nanoparticles for Efficient Chemo‐Immunotherapy

Nanomaterial-assisted delivery of CpG oligodeoxynucleotides for boosting cancer immunotherapy

Enhancing cancer chemo-immunotherapy by biomimetic nanogel with tumor targeting capacity and rapid drug-releasing in tumor microenvironment

Core-shell Tecto Dendrimers Co-Deliver Drug/gene for Immunomodulation of Macrophages and Dendritic Cells and Checkpoint Blockade-Promoted Breast Cancer Chemoimmunotherapy

An immunostimulatory dual-functional nanocarrier that improves cancer immunochemotherapy

Triple-Combination Immunogenic Nanovesicles Reshape the Tumor Microenvironment to Potentiate Chemo-Immunotherapy in Preclinical Cancer Models

Immuno‐nanozymes Mediated Synergistic Chemodynamic/Immuno‐therapy with Potentiated Anti‐tumor Efficacy

Co-delivery of Chemotherapeutic Drugs and Immune Adjuvants by Nanoscale DNA Tetrahedrons for Synergistic Cancer Therapy

Stepwise Targeting and Tandem Responsive Peptide Nanoparticles Enhance Immunotherapy through Prolonged Drug Retention

Two‐Pronged Intracellular Co‐Delivery of Antigen and Adjuvant for Synergistic Cancer Immunotherapy

A Site-Oriented Nanosystem for Active Transcellular Chemo-Immunotherapy to Prevent Tumor Growth and Metastasis

A nanodrug provokes antitumor immune responses via synchronous multicellular regulation for enhanced cancer immunotherapy

Combination Nanodrug Delivery Systems Facilitate the Syncretism of Chemotherapy with Immunotherapy to Promote Cancer Treatment